Lv61
2258 积分 2023-09-18 加入
Causal survival analysis under competing risks using longitudinal modified treatment policies
3小时前
待确认
Transparent Reporting of Observational Studies Emulating a Target Trial—The TARGET Statement
8天前
已完结
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
9天前
已完结
High-Dose Chemotherapy for Breast Cancer
12天前
已完结
High-dose chemotherapy in breast cancer
12天前
已关闭
On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples From Clinical Oncology Data
1个月前
已关闭
Semaglutide Eligibility Across All Current Indications for US Adults
1个月前
已完结
Semaglutide Eligibility Across All Current Indications for US Adults
1个月前
已完结
Life's Essential 8 and 10-Year and Lifetime Risk of Atherosclerotic Cardiovascular Disease in China
1个月前
已完结
Cardiovascular event reduction among a US population eligible for semaglutide per the SELECT trial
1个月前
已完结
皖公网安备34019202002308
